Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06947304 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

StatusCompleted
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Primary completion date changed from estimate of Aug 2026 to Aug 13, 2026 · Study completion date changed from estimate of Sep 2026 to Sep 15, 2026 · Eligibility criteria expanded, about 15 words Show 3 more changesShow less
    • Primary completion date changed from estimate of Aug 2026 to Aug 13, 2026
    • Study completion date changed from estimate of Sep 2026 to Sep 15, 2026
    • Eligibility criteria expanded, about 15 words
  2. Enrollment closed, study ongoing Primary completion pushed from May 2026 to Aug 2026 · Enrollment increased: 8 → 9 participants · Completion pushed from May 2026 to Sep 2026 · 1 morev5 Show 4 more changesShow less
    • Primary completion pushed from May 2026 to Aug 2026
    • Enrollment increased: 8 → 9 participants
    • Completion pushed from May 2026 to Sep 2026
    • Site details revised
  3. Primary endpoints revised (2) Primary and study completion dates: Mar 2026 to May 2026 · Secondary endpoint revised · Study description revised · 1 morev4 Show 4 more changesShow less
    • Primary and study completion dates: Mar 2026 to May 2026
    • Secondary endpoint revised
    • Study description revised
    • Site contact updated

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Aug 1, 2025 to Aug 22, 2025 Eligibility criteria shortened, about 55 wordsv3 Show 1 more changeShow less
    • Eligibility criteria shortened, about 55 words

    See this version in full on ClinicalTrials.gov ↗

  5. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Sep 30, 2025 to Mar 2026 · Start date changed from estimate of Jun 16, 2025 to Aug 1, 2025 · Site details revisedv2 Show 3 more changesShow less
    • Primary and study completion dates: Sep 30, 2025 to Mar 2026
    • Start date changed from estimate of Jun 16, 2025 to Aug 1, 2025
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients with Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Trial Details
NCT Number NCT06947304
Lead Sponsor Corcept Therapeutics
Collaborators: University of Missouri-Columbia
Conditions Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Non-alcoholic Fatty Liver Disease (NAFLD)
Enrollment 9 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov